DR. TODD F. STOCKSTILL, MD

MEMPHIS, TN

Research Active
Radiology - Radiation Oncology NPI registered 21+ years 1 publication 2021 – 2021 NPI: 1548263916
Radiology - Radiation Oncology
Prostatic NeoplasmsLaparoscopyRobotic Surgical ProceduresPropensity ScoreProstatectomyProportional Hazards ModelsKaplan-Meier EstimateInterrupted Time Series Analysis

Practice Location

1265 UNION AVE
MEMPHIS, TN 38104-3415

Phone: (901) 726-7358

What does TODD STOCKSTILL research?

Dr. Stockstill studies the effectiveness of different surgical approaches for treating localized prostate cancer. Specifically, he compares robotic-assisted laparoscopic prostatectomy (RALP) to open radical prostatectomy (ORP) to understand which method provides better survival outcomes for patients. His work is particularly important for men diagnosed with localized prostate cancer, as it helps inform treatment decisions and highlights the potential benefits of opting for robotic surgery.

Key findings

  • Patients who underwent robotic-assisted laparoscopic prostatectomy (RALP) had a 3.9% chance of dying within five years, compared to a 5.5% chance for those who had open radical prostatectomy (ORP).
  • RALP provides a significant survival advantage over traditional surgical methods, which justifies the higher costs associated with robotic surgery.
  • The study emphasizes the importance of choosing the right surgical method to improve patient outcomes in localized prostate cancer cases.

Frequently asked questions

Does Dr. Stockstill study prostate cancer?
Yes, Dr. Stockstill specifically studies localized prostate cancer and the effectiveness of surgical treatments.
What treatments has Dr. Stockstill researched?
He has researched robotic-assisted laparoscopic prostatectomy (RALP) and open radical prostatectomy (ORP) as surgical treatments for prostate cancer.
Is Dr. Stockstill's work relevant to patients with localized prostate cancer?
Absolutely, his research is directly relevant to patients with localized prostate cancer as it provides insights into the best surgical options for improving survival.

Publications in plain English

Survival After Robotic-assisted Prostatectomy for Localized Prostate Cancer: An Epidemiologic Study.

2021

Annals of surgery

Wang Y, Gieschen H, Greenberger M, Yu X, Tian G +7 more

Plain English
This study looked at the survival rates of prostate cancer patients who had surgery using two different methods: robotic-assisted laparoscopic prostatectomy (RALP) and open radical prostatectomy (ORP). They found that patients who underwent RALP had a lower chance of dying within five years (3.9%) compared to those who had ORP (5.5%), translating to a significant survival advantage for RALP. This matters because it suggests that RALP not only improves survival outcomes but also helps justify its higher costs in clinical practice. Who this helps: Patients with localized prostate cancer.

PubMed

Frequent Co-Authors

Yuefeng Wang Holger Gieschen Mark Greenberger Xinhua Yu Gary Tian Noam VanderWalde Michael Farmer Lillian Rinker Enrique W Izaguirre Bradley Somer

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.